Alnylam Pharmaceuticals
ALNY
#789
Rank
NZ$56.04 B
Marketcap
NZ$418.82
Share price
-2.42%
Change (1 day)
-46.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company